86. Onabotulinumtoxin-A treatment in chronic migraine with medication overuse: A two years Italian experience

2017 ◽  
Vol 128 (12) ◽  
pp. e435
Author(s):  
C. Butera ◽  
B. Colombo ◽  
F. Bianchi ◽  
S. Amadio ◽  
R. Guerriero ◽  
...  
2018 ◽  
Vol 39 (S1) ◽  
pp. 173-174 ◽  
Author(s):  
Licia Grazzi ◽  
Eleonora Grignani ◽  
Emanuela Sansone ◽  
Alberto Raggi ◽  
Matilde Leonardi ◽  
...  

2004 ◽  
Vol 44 (7) ◽  
pp. 678-683 ◽  
Author(s):  
Licia Grazzi ◽  
Frank Andrasik ◽  
Domenico D'Amico ◽  
Susanna Usai ◽  
Steven Kass ◽  
...  

Author(s):  
Mr. Ghene Mauli Ganesh

Abstract: Migraine is the most common disabling brain disorder. Chronic migraine, a condition characterized by the experience of migrainous headache on at least 15 days per month, is highly disabling. Patients with chronic migraine present to primary care, are often referred for management to secondary care, and make up a large proportion of patients in specialist headache clinics. Many patients with chronic migraine also have medication overuse, defined as using a compound analgesic, opioid, triptan or ergot derivative on at least 10 days per month. All doctors will encounter patients with chronic headaches. A basic working knowledge of the common primary headaches, and a rational manner of approaching the patient with these conditions, allows a specific diagnosis of chronic migraine to be made quickly and safely, and by making this diagnosis one opens up a substantial number of acute and preventive treatment options. This article discusses the current state of management of chronic migraine.


2011 ◽  
Vol 12 (4) ◽  
pp. 459-466 ◽  
Author(s):  
Marian Gómez-Beldarrain ◽  
María Carrasco ◽  
Amaia Bilbao ◽  
Juan C. García-Moncó

2014 ◽  
Vol 54 (10) ◽  
pp. 1565-1573 ◽  
Author(s):  
John F. Rothrock ◽  
Lisa M. Bloudek ◽  
Timothy T. Houle ◽  
Diane Andress‐Rothrock ◽  
Sepideh F. Varon

Author(s):  
Giovanni D’Andrea ◽  
Antonina Gucciardi ◽  
Giuseppe Giordano ◽  
Gennaro Bussone ◽  
Alberta Leon

2020 ◽  
Author(s):  
Marco Antonio Takashi Utiumi ◽  
João Guilherme Bochnia Küster ◽  
Keryn Sporh Godk ◽  
Nikolai José Eustátios Kotsifas ◽  
Pedro André Kowacs ◽  
...  

Abstract Background: The pain location of migraine has limited diagnostic value and has usually been assessed using non-standard verbal descriptors.Methods: This study uses non-verbal descriptors of pain location in episodic and chronic migraineurs seen at 3 centers of different complexities (tertiary-level hospital and outpatient clinics) and from different sectors (public and private). The explicit pain location was recorded by asking patients to indicate in an electronic form 3 points on the anterolateral side and 3 points on the posterolateral side of the head and neck. A multivariate logistic regression model was fitted to assess the association of different pain location patterns with demographic and clinical variables.Results: Ninety-seven episodic migraine and 113 chronic migraine patients were included, with the most commonly affected sites being the frontal (73% and 65%, respectively), temporal (67% and 73%, respectively) and parietal (27% and 34%, respectively) regions. The posterior cervical site was most often involved in the chronic migraine group (21% vs. 33%, p=0.034). No other locations showed a significant difference. The adjusted model showed that diffuse pain (OR=13.74, CI=4.89-49.85) and the presence of medication overuse associated with tactile allodynia (OR=2.65, CI=1.05-6.87) were associated with increased odds of neck pain. Disease duration was marginally relevant (p=0.078).Conclusions: The migraine attacks most commonly involve the fronto-temporal regions, although neck pain can be more often found in chronic migraine. Some features commonly found in this group such as more diffuse pain, tactile allodynia, and medication overuse are associated with this extratrigeminal site of pain.


Sign in / Sign up

Export Citation Format

Share Document